Monographella albescens
Monographella albescens
Description
Monographella albescens is a fungal plant pathogen within the Ascomycota phylum, responsible for the disease known as rice leaf scald. This pathogen represents a significant challenge for rice cultivation worldwide, particularly in regions characterized by high humidity and temperate to warm climatic conditions, where it can cause considerable yield losses.
The disease primarily manifests as leaf lesions that start as gray or brownish spots, eventually turning into bleached or grayish-white areas. In severe cases, the lesions cover the entire leaf blade, causing the tissue to become dry, brittle, and necrotic, which prevents the plant from maintaining the necessary photosynthetic rate for optimal grain filling.
The biological cycle of the fungus is characterized by the formation of perithecia on infested rice stubble during the off-season. When environmental conditions improve, ascospores and conidia are released, serving as primary and secondary inoculum sources. The spread of the fungus is facilitated primarily by rain splashes and wind, which distribute the spores onto healthy host tissues during the vegetative stages of the crop.
The impact of this pathogen on rice production is substantial. By damaging the leaf canopy, Monographella albescens reduces the overall vitality of the plant. This leads to stunted growth, poor grain development, and a reduction in both the weight and quality of the final harvest. Early detection and monitoring are essential to manage the disease effectively.
Control measures are centered on an integrated pest management approach. Key practices include:
- Utilizing certified, pathogen-free seeds for planting.
- Deep plowing and removing rice stubble to reduce the primary inoculum load in the field.
- Implementing proper water management practices to avoid excessive humidity in the crop canopy.
- Applying recommended systemic fungicides during the tillering stage if environmental conditions favor disease development.
Вызывает болезни · 3
Discussion
No discussions yet — be the first.